Fig. 3.
Fig. 3. Kaplan-Meier product-limit estimate of disease-free survival from the time of random assignment to maintenance with ATRA (all-trans retinoic acid) or to observation (P < .0001).

Kaplan-Meier product-limit estimate of disease-free survival from the time of random assignment to maintenance with ATRA (all-trans retinoic acid) or to observation (P < .0001).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal